Ken Griffin Takeda Pharmaceutical CO LTD Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$12.6 - $13.67 $45,360 - $49,212	3,600 Added 163.64%	5,800 $75,000
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $427,812 - $463,232	-30,800 Reduced 93.33%	2,200 $30,000
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $561,120 - $648,060	-42,000 Reduced 56.0%	33,000 $470,000
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $33,066 - $35,904	-2,200 Reduced 2.85%	75,000 $1.16 Million
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $365,895 - $402,085	-23,500 Reduced 23.34%	77,200 $1.21 Million
Q1 2023 May 15, 2023	SELL	$15.28 - $16.48 $403,392 - $435,072	-26,400 Reduced 20.77%	100,700 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $223,560 - $281,160	18,000 Added 16.5%	127,100 $1.98 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $102,400 - $229,200	8,000 Added 7.91%	109,100 $1.42 Million

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.